Laser acupuncture compared with oral glucose administration for pain prevention in healthy term neonates undergoing routine heel sticks/lance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010122

Enrollment

Registered

2016-03-02

Start date

2016-03-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.0

Interventions

Group 1: Healthy term neonates (> 37. gestational age) receive oral glucose solution 2 minutes before the intervention (heel stick) (Glux® from Pharma Stulln, Germany - 30% glucose solution Dosage: 0,

Eligibility

Sex/Gender

All

Age

2 Days to 5 Days

Inclusion criteria

Inclusion criteria: Term newborn (> 37. gestational age) Healthy neonate without clinical and/or congenital complications Age: between 2nd and 5th days postnatal By the parents signed written informed consent Spontaneous delivery or Caesarean sectio

Exclusion criteria

Exclusion criteria: Lack of written informed consent Preterm newborn (<37. gestational age) Clinical and/or congenital diseases Current pain therapy in the newborn and/or in the breast-feeding mother

Design outcomes

Primary

Measure	Time frame
Differences in premature infant pain profile (=PIPP) score between glucose group (= GG) and acupuncture group (= AG), assessed by a blinded skilled nurse according to the video recordings of the heel stick.	—

Secondary

Measure	Time frame
Changes in heart rate Changes in oxygen saturation Cry time Any Adverse effects	—

Countries

Austria

Contacts

Public ContactWolfgang Raith

Univ. Klinik für Kinder und Jugendheilkunde

wolfgang.raith@klinikum-graz.at+43 316 385 80599

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026